Author:
Jiang Shuai,Wang Bao,Zhang Mengzhe,Liu Zuo,Xiao Zengtuan,Gong Jialin,Wang Xiaofei,Zhang Zhenning,Zhang Zhenfa
Abstract
Abstract
Background
This study aimed to compare the postoperative quality of life (PQOL) between non–small–cell lung cancer (NSCLC) patients who underwent video–assisted thoracoscopic sublobar resection (subsegment, segment, or wedge) and lobectomy. Meanwhile, we developed a PQOL scale for patients with NSCLC after optimization.
Methods
Developing and evaluating the postoperative quality–of–life scale of non–small–cell lung cancer (NSCLC–PQOL) followed by the international principles for developing quality–of–life scale. Therefore, we used the NSCLC–PQOL scale to evaluate the PQOL of patients who underwent different surgeries.
Results
The overall PQOL of patients who underwent video-assisted thoracoscopic lobectomy and sublobar resection gradually worsened from discharge to 3 months postoperatively and progressively improved from three to 6 months postoperatively. And the sublobar resection group showed better PQOL in chest tightness, breath shortness, breathlessness, cough and expectoration than the lobectomy group, and the differences were statistically significant (P < 0.05). The final version of the NSCLC–PQOL contained three dimensions: “signs–symptoms”, “psychological and psychiatric”, and “social–life” dimensions.
Conclusions
The sublobar resection group showed better PQOL in “chest tightness”, “breath shortness”, “breathlessness”, “cough”, and “expectoration” than the lobectomy group. Twenty–two items formed a well–behaved PQOL scale after being validated satisfactorily. The scale was a suitable rating tool for evaluating the NSCLC–PQOL of patients.
Trial registration
As this study was a retrospective study and not a clinical trial, we did not register this study in the Chinese Clinical Trial Registry.
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;20(2):1–41.
2. Herbst RS, Morgensztern D, Boshoff C. The biology and management of non–small cell lung cancer. Nature. 2018;553(7689):446–54.
3. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non–small cell lung cancer. Lung Cancer study group. Ann Thorac Surg. 1995;60(3):615–22.
4. Zhang Y, Fu F, Chen H. Management of ground–glass opacities in the lung cancer spectrum. Ann Thorac Surg. 2020;110(6):1796–804.
5. Nakamura H, Kawasaki N, Taguchi M, Kabasawa k. Survival following lobectomy vs limited resection for stage I lung cancer: a meta–analysis. Br J Cancer. 2005;92(6):1033–7.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献